Platelet-activating factor antagonist WEB-2170 inhibits lipopolysaccharide-induced, but not antiprogestin-induced, preterm cervical ripening in timed-pregnant rats

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 963-967

  Maul, Holger ^a   Shi, Leili ^b   Marx, Stephen G ^a   Garfield, Robert E ^a   Saade, George R ^a,b  

^a Division of Rehabilitation Sciences   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Light induced fluorescence; Parturition; Platelet activating factor; Uterine cervix

Indexed keywords

ANTIGESTAGEN; BEPAFANT; LIPOPOLYSACCHARIDE; MIFEPRISTONE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE ANALYSIS; INFECTION; LIGHT INDUCED FLUORESCENCE; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RAT; UTERINE CERVIX RIPENING;

EID: 0242425768     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00722-1     Document Type: Article

References (25)

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339:313-20.
2. Robertson PA, Sniderman SH, Laros RK Jr, Cowan R, Heilbron D, Goldenberg RL, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol 1992;166:1629-41.
3. Ludmir J, Sehdev HM. Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol 2000;43:433-9.
4. Chwalisz K, Garfield RE. Antiprogestins in the induction of labor. Ann N Y Acad Sci 1994;734:387-413.
5. Junqueira LC, Zugaib M, Montes GS, Toledo OM, Krisztan RM, Shigihara KM. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980;138:273-81.
6. Glassman W, Byam-Smith M, Garfield RE. Changes in rat cervical collagen during gestation and after antiprogesterone treatment as measured in vivo with light-induced autofluorescence. Am J Obstet Gynecol 1995;173:1550-6.
7. Shi L, Shi SQ, Saade GR, Chwalisz K, Garfield RE. Changes in cervical resistance and collagen fluorescence during gestation in rats. J Perinat Med 1999;27:188-94.
8. Sennstrom MB, Ekman G, Westergren-Thorsson G, Malmstrom A, Bystrom B, Endresen U, et al. Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod 2000;6:375-81.
9. Calder AA, Embrey MP, Tait T. Ripening of the cervix with extraamniotic prostaglandin E2 in viscous gel before induction of labour. BJOG 1977;84:264-8.
10. Shi L, Shi SQ, Saade GR, Chwalisz K, Garfield RE. Studies of cervical ripening in pregnant rats: effects of various treatments. Mol Hum Reprod 2000;6:382-9.
11. Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C. Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 1994;9:2173-81.
12. Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. BJOG 1997;104:1054-7.
13. Kniss DA, Iams JD. Regulation of parturition update: endocrine and paracrine effectors of term and preterm labor. Clin Perinatol 1998;25:819-36.
14. Maul H, Shi L, Marx SG, Garfield RE, Saade GR. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol 2002;187:829-33.
15. Nishihira J, Ishibashi T, Imai Y, Muramatsu T. Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn- glycero-3-phosphocholine) in human amniotic fluid during labor. Lipids 1984;19:907-10.
16. Ihara Y, Frenkel RA, Johnston JM. Hormonal regulation of platelet-activating factor-acetyltransferase activity in rat tissues. Arch Biochem Biophys 1993;304:503-7.
17. Li L, Yasuda K, Matsubara T, Okada H, Nakajima T, Sanezumi M, et al. Estrogen effects on platelet-activating factor and platelet-activating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy. Prostaglandins Other Lipid Mediat 1999;57:219-30.
18. Zhu YP, Hoffman DR, Hwang SB, Miyaura S, Johnston JM. Prolongation of parturition in the pregnant rat after treatment with a platelet activating factor receptor antagonist. Biol Reprod 1991;44:39-42.
19. Muguruma K, Narahara H, Kawano Y, Johnston JM. Platelet activating factor in reproduction. Infert Reprod Med Clin North Am. 1997;8:1-25.
20. Alloatti G, Penna C, Mariano F, Camussi G. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol Regul Integr Comp Physiol 2000;279:R2156-63.
21. Kulikov VI, Muzya GI. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions. Biochemistry (Mosc) 1998;63:47-57.
22. Sugano T, Nasu K, Narahara H, Kawano Y, Nishida Y, Miyakawa I. Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts. Biol Reprod 2000;62:540-6.
23. Yasuda K, Furukawa M, Johnston JM. Effect of estrogens on plasma platelet-activating factor acetylhydrolase and the timing of parturition in the rat. Biol Reprod 1996;54:224-9.
24. Maul H, Marx SG, Fittkow C, Howard K, Saade G, Garfield RE. Platelet-activating factor acetylhydrolase messenger RNA is downregulated around term in uterine cervices of pregnant rats [abstract]. J Soc Gynecol Investig 2002;9(suppl):752.
25. Bienkiewicz A, Pajszczyk-Kieszkiewicz T, Kus E, Dabrowski R. The effect of platelet activating factor antagonist (BN 52021) on pregnancy duration and collagen content in the pregnant rat uterus and cervix. Endocr Res 1994;20:387-93.